CSat Investment Advisory’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-401
Closed -$41K 667
2020
Q3
$41K Buy
401
+32
+9% +$2.76K ﹤0.01% 694
2020
Q2
$32K Sell
369
-457
-55% -$36.5K ﹤0.01% 737
2020
Q1
$48K Buy
826
+131
+19% +$10.6K 0.01% 531
2019
Q4
$64K Sell
695
-1,171
-63% -$103K 0.02% 529
2019
Q3
$169K Buy
1,866
+325
+21% +$37K 0.05% 232
2019
Q2
$182K Buy
+1,541
New +$155K 0.06% 202

Other funds holding EXAS

CSat Investment Advisory's EXAS Position: Q4 2020 in Review

CSat Investment Advisory sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 401 shares — an estimated $41K sold.

CSat Investment Advisory first reported a position in EXAS in Q2 2019 and held it in 6 quarters. The position peaked at $182K in Q2 2019. 622 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • CSat Investment Advisory reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 401 Exact Sciences shares in Q4 2020, an estimated $41K.
  • CSat Investment Advisory first reported a position in Exact Sciences in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Exact Sciences position peaked at $182K in Q2 2019.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.